BIOLIFE SOLUTIONS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biolife Solutions Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q1 2024.
  • Biolife Solutions Inc Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2024 was $54.7M, a 36.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $54.7M +$14.6M +36.4% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $49.5M +$16.1M +48.2% Dec 31, 2023 10-K 2024-02-29
Q3 2023 $48.2M +$27.7M +135% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $44.1M +$22.5M +104% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $40.1M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $33.4M +$30.4M +1016% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $20.5M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $21.6M Jun 30, 2022 10-Q 2022-08-09
Q4 2021 $2.99M -$5.51M -64.8% Dec 31, 2021 10-K 2024-02-29
Q4 2020 $8.5M -$208K -2.39% Dec 31, 2020 10-K 2024-02-29
Q4 2019 $8.71M +$361K +4.33% Dec 31, 2019 10-K 2023-03-31
Q4 2018 $8.35M -$412K -4.71% Dec 31, 2018 10-K 2022-03-31
Q4 2017 $8.76M -$3.42M -28.1% Dec 31, 2017 10-K 2019-03-15
Q4 2016 $12.2M +$38.1K +0.31% Dec 31, 2016 10-K 2018-03-09
Q4 2015 $12.1M +$22.8M Dec 31, 2015 10-K 2017-03-15
Q4 2014 -$10.7M -$1.12M -11.7% Dec 31, 2014 10-K 2016-02-25
Q4 2013 -$9.59M -$342K -3.7% Dec 31, 2013 10-K 2015-03-12
Q4 2012 -$9.24M -$30.4K -0.33% Dec 31, 2012 10-K 2014-02-12
Q4 2011 -$9.21M Dec 31, 2011 10-K 2013-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.